Comerica Bank’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$1.32M Buy
17,426
+16,903
+3,232% +$1.23M 0.01% 1352
2025
Q3
$32.1K Buy
523
+469
+869% +$24.4K ﹤0.01% 2969
2025
Q2
$2.64K Hold
54
﹤0.01% 3468
2025
Q1
$2.75K Hold
54
﹤0.01% 3424
2024
Q4
$2.44K Buy
54
+33
+157% +$1.41K ﹤0.01% 3450
2024
Q3
$779 Hold
21
﹤0.01% 3588
2024
Q2
$642 Hold
21
﹤0.01% 3614
2024
Q1
$611 Hold
21
﹤0.01% 3665
2023
Q4
$579 Sell
21
-294
-93% -$6.72K ﹤0.01% 3664
2023
Q3
$7.06K Buy
+315
New +$11.7K ﹤0.01% 3279

Other funds holding PTCT

Comerica Bank's PTCT Position: Q4 2025 in Review

Comerica Bank increased its PTC Therapeutics (PTCT) stake by 3,232% in Q4 2025, buying an estimated $1.23M and bringing the position to 17,426 shares worth $1.32M. The position accounts for 0.01% of the portfolio, ranked #1352.

Comerica Bank first reported a position in PTCT in Q3 2023 and has held it in 10 quarters since. 353 funds tracked by Wall St. Rank hold PTCT as of Q4 2025.

  • Comerica Bank held 17,426 shares of PTC Therapeutics worth $1.32M as of Q4 2025.
  • Comerica Bank bought 16,903 PTC Therapeutics shares in Q4 2025, an estimated $1.23M.
  • PTC Therapeutics made up 0.01% of Comerica Bank's portfolio in Q4 2025, its #1352 holding.
  • Comerica Bank first reported a position in PTC Therapeutics in Q3 2023 and has held it in 10 quarters since.
  • 353 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.